142 related articles for article (PubMed ID: 28719622)
1. Characterization of plasma metal profiles in Alzheimer's disease using multivariate statistical analysis.
Guan C; Dang R; Cui Y; Liu L; Chen X; Wang X; Zhu J; Li D; Li J; Wang D
PLoS One; 2017; 12(7):e0178271. PubMed ID: 28719622
[TBL] [Abstract][Full Text] [Related]
2. Characterization of metal profiles in serum during the progression of Alzheimer's disease.
González-Domínguez R; García-Barrera T; Gómez-Ariza JL
Metallomics; 2014 Feb; 6(2):292-300. PubMed ID: 24343096
[TBL] [Abstract][Full Text] [Related]
3. Plasma metals as potential biomarkers in dementia: a case-control study in patients with sporadic Alzheimer's disease.
Xu J; Church SJ; Patassini S; Begley P; Kellett KAB; Vardy ERLC; Unwin RD; Hooper NM; Cooper GJS
Biometals; 2018 Apr; 31(2):267-276. PubMed ID: 29516299
[TBL] [Abstract][Full Text] [Related]
4. Serum fatty acid profiles using GC-MS and multivariate statistical analysis: potential biomarkers of Alzheimer's disease.
Wang DC; Sun CH; Liu LY; Sun XH; Jin XW; Song WL; Liu XQ; Wan XL
Neurobiol Aging; 2012 Jun; 33(6):1057-66. PubMed ID: 20980076
[TBL] [Abstract][Full Text] [Related]
5. A blood-based, 7-metabolite signature for the early diagnosis of Alzheimer's disease.
Olazarán J; Gil-de-Gómez L; Rodríguez-Martín A; Valentí-Soler M; Frades-Payo B; Marín-Muñoz J; Antúnez C; Frank-García A; Acedo-Jiménez C; Morlán-Gracia L; Petidier-Torregrossa R; Guisasola MC; Bermejo-Pareja F; Sánchez-Ferro Á; Pérez-Martínez DA; Manzano-Palomo S; Farquhar R; Rábano A; Calero M
J Alzheimers Dis; 2015; 45(4):1157-73. PubMed ID: 25649659
[TBL] [Abstract][Full Text] [Related]
6. Metal concentrations in plasma and cerebrospinal fluid in patients with Alzheimer's disease.
Gerhardsson L; Lundh T; Minthon L; Londos E
Dement Geriatr Cogn Disord; 2008; 25(6):508-15. PubMed ID: 18463412
[TBL] [Abstract][Full Text] [Related]
7. Blood-based diagnosis of Alzheimer's disease using fingerprinting metabolomics based on hydrophilic interaction liquid chromatography with mass spectrometry and multivariate statistical analysis.
Inoue K; Tsuchiya H; Takayama T; Akatsu H; Hashizume Y; Yamamoto T; Matsukawa N; Toyo'oka T
J Chromatogr B Analyt Technol Biomed Life Sci; 2015 Jan; 974():24-34. PubMed ID: 25463194
[TBL] [Abstract][Full Text] [Related]
8. Elevation of the Plasma Aβ40/Aβ42 Ratio as a Diagnostic Marker of Sporadic Early-Onset Alzheimer's Disease.
Kim HJ; Park KW; Kim TE; Im JY; Shin HS; Kim S; Lee DH; Ye BS; Kim JH; Kim EJ; Park KH; Han HJ; Jeong JH; Choi SH; Park SA
J Alzheimers Dis; 2015; 48(4):1043-50. PubMed ID: 26444752
[TBL] [Abstract][Full Text] [Related]
9. Discovery and Confirmation of Diagnostic Serum Lipid Biomarkers for Alzheimer's Disease Using Direct Infusion Mass Spectrometry.
Anand S; Barnes JM; Young SA; Garcia DM; Tolley HD; Kauwe JSK; Graves SW
J Alzheimers Dis; 2017; 59(1):277-290. PubMed ID: 28598845
[TBL] [Abstract][Full Text] [Related]
10. Plasma protein profiling for potential biomarkers in the early diagnosis of Alzheimer's disease.
Kitamura Y; Usami R; Ichihara S; Kida H; Satoh M; Tomimoto H; Murata M; Oikawa S
Neurol Res; 2017 Mar; 39(3):231-238. PubMed ID: 28107809
[TBL] [Abstract][Full Text] [Related]
11. Trace metal concentrations in hair and nails from Alzheimer's disease patients: Relations with clinical severity.
Koseoglu E; Koseoglu R; Kendirci M; Saraymen R; Saraymen B
J Trace Elem Med Biol; 2017 Jan; 39():124-128. PubMed ID: 27908403
[TBL] [Abstract][Full Text] [Related]
12. Discovery and Subsequent Confirmation of Novel Serum Biomarkers Diagnosing Alzheimer's Disease.
Shah DJ; Rohlfing F; Anand S; Johnson WE; Alvarez MT; Cobell J; King J; Young SA; Kauwe JS; Graves SW
J Alzheimers Dis; 2016; 49(2):317-27. PubMed ID: 26484917
[TBL] [Abstract][Full Text] [Related]
13. Concentrations of metals, beta-amyloid and tau-markers in cerebrospinal fluid in patients with Alzheimer's disease.
Gerhardsson L; Blennow K; Lundh T; Londos E; Minthon L
Dement Geriatr Cogn Disord; 2009; 28(1):88-94. PubMed ID: 19672066
[TBL] [Abstract][Full Text] [Related]
14. Serum MicroRNA Profiles Serve as Novel Biomarkers for the Diagnosis of Alzheimer's Disease.
Dong H; Li J; Huang L; Chen X; Li D; Wang T; Hu C; Xu J; Zhang C; Zen K; Xiao S; Yan Q; Wang C; Zhang CY
Dis Markers; 2015; 2015():625659. PubMed ID: 26078483
[TBL] [Abstract][Full Text] [Related]
15. Increasing the predictive accuracy of amyloid-β blood-borne biomarkers in Alzheimer's disease.
Watt AD; Perez KA; Faux NG; Pike KE; Rowe CC; Bourgeat P; Salvado O; Masters CL; Villemagne VL; Barnham KJ
J Alzheimers Dis; 2011; 24(1):47-59. PubMed ID: 21157020
[TBL] [Abstract][Full Text] [Related]
16. Cerebrospinal fluid/plasma quotients of essential and non-essential metals in patients with Alzheimer's disease.
Gerhardsson L; Lundh T; Londos E; Minthon L
J Neural Transm (Vienna); 2011 Jun; 118(6):957-62. PubMed ID: 21373763
[TBL] [Abstract][Full Text] [Related]
17. Role of Plasma Clusterin in Alzheimer's Disease-A Pilot Study in a Tertiary Hospital in Northern India.
Vishnu VY; Modi M; Sharma S; Mohanty M; Goyal MK; Lal V; Khandelwal N; Mittal BR; Prabhakar S
PLoS One; 2016; 11(11):e0166369. PubMed ID: 27861589
[TBL] [Abstract][Full Text] [Related]
18. The efficacy of plasma biomarkers in early diagnosis of Alzheimer's disease.
Wang T; Xiao S; Liu Y; Lin Z; Su N; Li X; Li G; Zhang M; Fang Y
Int J Geriatr Psychiatry; 2014 Jul; 29(7):713-9. PubMed ID: 24318929
[TBL] [Abstract][Full Text] [Related]
19. Correlation between metal ions and clinical findings in subjects affected by Alzheimer's disease.
Bomboi G; Marchione F; Sepe-Monti M; De Carolis A; Bianchi V; Medda E; Pino A; Bocca B; Forte G; D'Ippolito C; Giubilei F
Ann Ist Super Sanita; 2005; 41(2):205-12. PubMed ID: 16244394
[TBL] [Abstract][Full Text] [Related]
20. Plasminogen activator inhibitor-1 as an early potential diagnostic marker for Alzheimer's disease.
Oh J; Lee HJ; Song JH; Park SI; Kim H
Exp Gerontol; 2014 Dec; 60():87-91. PubMed ID: 25304332
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
